Efficacy of systemic HS-198, an analogue of oxymorphone, on cancer pain-related behaviour in mice

IF 2.9 3区医学 Q2 Medicine

BMC Pharmacology & Toxicology Pub Date : 2011-09-05 DOI:10.1186/1471-2210-11-S2-A4

M. F. Asim, C. Bohotin, C. Constantin, H. Schmidhammer, M. Kress, M. Spetea

引用次数: 0

查看原文本刊更多论文

羟吗啡酮类似物HS-198对小鼠癌痛相关行为的影响

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Pharmacology & Toxicology PHARMACOLOGY & PHARMACY-TOXICOLOGY

CiteScore

4.40

自引率

0.00%

发文量

审稿时长

12 weeks

期刊介绍： BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.